Qure.ai has partnered with Microsoft to onboard its end-to-end lung cancer detection, measurement and management suite onto Microsoft’s Precision Imaging Network. The move is positioned to streamline ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.

Abstract: Lung cancer continues to be a leading cause of cancer-related mortality globally, primarily due to late-stage diagnosis. Non-invasive diagnostic techniques, especially those based on exhaled ...

CARBONDALE, Ill. (WSIL) -- SIH Memorial Hospital of Carbondale has introduced Ion® robotic technology to advance lung cancer detection. This makes SIH the only health system in the southernmost 16 ...

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. Lung cancer is the deadliest cancer among women in the United States, surpassing the mortality numbers of breast and ...

Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective individualized ...

Not smoking is still the best way to lower your risk of lung cancer. But doctors are seeing something unexpected: more people who have never smoked are being diagnosed with the disease. “It’s ...

CARBONDALE, Ill. (WSIL) -- Southern Illinois Healthcare (SIH) has introduced a groundbreaking advancement in lung care for the region. SIH Memorial Hospital of Carbondale recently performed the first ...

OCTOBER IS BREAST CANCER AWARENESS MONTH, AND TODAY WE ARE JOINED BY DOCTOR JULIAN BRICKELL. A JUPITER MEDICAL CENTER BREAST SURGICAL ONCOLOGIST, TO TALK ABOUT THE LATEST UPDATES AND EARLY DETECTION ...

Shared decision-making in ALK-positive NSCLC is crucial, with patient-authored guides aiding in managing lorlatinib side effects and empowering patients. Newly diagnosed lung cancer patients benefit ...

Extensive Validation of BioMark’s Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.